Source: Eur Respir J, 57 (3) 2004466; 10.1183/13993003.04466-2020



Rating:

Share or cite this content

Citations should be made in the following way:
Kjetil Ask, Megan Vierhout, Anna Dvorkin-Gheva, Wei Shi. Mononuclear phagocytic system and fibrosis: back to the future?. Eur Respir J, 57 (3) 2004466; 10.1183/13993003.04466-2020

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary alveolar proteinosis: iPS derived macrophages as in-vitro disease model and potential source for novel gene and cell therapies Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Role of macrophage activation in type II alveolar cells transplantation for the treatment of idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung Year: 2013 MiR-185/AKT and miR-29a/collagen 1a pathways are activated in IPF alveolar macrophages Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Mast cells in lung disease: clinical implications Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications Year: 2019 Antibiotic therapy affects functional behaviour in cystic fibrosis blood mononuclear cells Source: Eur Respir J 2015; 46: 558-561 Year: 2015 Regulation of immune cells in lung fibrosis: the reign of regnase-1? Source: Eur Respir J, 57 (3) 2004029; 10.1183/13993003.04029-2020 Year: 2021 Neutrophils in chronic inflammatory airway diseases: can we target them and how? Source: Eur Respir J 2010; 35: 467-469 Year: 2010 Alveolar macrophages and pulmonary microbiota are interconnected indicators of lung ecology post-transplantation Source: International Congress 2015 – Predictors of lung transplant complications Year: 2015 Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: Role of transmembrane SCF and PAR-2/PKCalpha/Raf-1/p44/42 signaling pathway Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Epithelial pIgR: A new player in idiopathic pulmonary fibrosis? Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases Year: 2018 The evaluation of oxygen-activating function of mononuclear phagocytes in sarcoidosis Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis Year: 2008 Role of polymorphonuclear neutrophils (PMN) in Interleukin-1β (IL-1β) processing during bacterial lung infection: Relevance to cystic fibrosis (CF) Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment Year: 2015 LSC - 2019 - Inflammasomes’ activation in alveolar macrophages and peripheral blood mononuclear cells in fibrotic Interstitial Lung Diseases Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019 LSC 2011 Abstract: Role of mast cells and chymase in idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases Year: 2011 Lipid laden macrophage index: a useful investigation? Source: Eur Respir J 2004; 24: Suppl. 48, 376s Year: 2004 Eosinophils and eosinophilic immune dysfunction in health and disease Source: Eur Respir Rev, 31 (163) 210150; 10.1183/16000617.0150-2021 Year: 2022 Circulating fibrocytes: a role in pulmonary circulation? Source: Eur Respir J 2006; 28: Suppl. 50, 546s Year: 2006 COPD monocytes differentiate into pro-inflammatory macrophages regardless of environment Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 Location or origin? What is critical for macrophage propagation of lung fibrosis? Source: Eur Respir J, 51 (3) 1800103; 10.1183/13993003.00103-2018 Year: 2018